switching from mounjaro to retatrutide Wegovy Tirzepatide vs. Retatrutide: Key Differences

At week 36, the 12mg group showed the most dramatic eating behavior changes: Perceived hunger decreased by 2.4 points versus placebo Disinhibition improved by 2.6 points Dietary restraint increased by 3.3 points 100% of participants achieved at least 5% body weight loss by week 48 83% achieved 15% or greater weight loss Mean weight reduction reached 24.2% at 48 weeks These numbers represent the strongest weight loss and appetite-related outcomes ever recorded in clinical trials for any GLP-1 class medication

4 in 10 consider it an immediate concern and intend to offer in 2024

But there's little direct evidence to back up most of these statements

William Blair analysts said in February 2024 that they worry the most about Shake Shack, which entered the Canadian market last year